Form 4: KEWAUNEE SCIENTIFIC CEO Thomas Hull III Reports RSU Vesting and Tax-Related Share Disposition

Thomas David Hull III, President, CEO, and Director of Kewaunee Scientific Corp, reported the vesting of 12,130 restricted stock units and the subsequent disposition of 3,483 shares for tax withholding purposes.

Summary

• Thomas David Hull III, President, CEO, and Director of Kewaunee Scientific Corp, acquired 12,130 shares of common stock on June 30, 2025, through the vesting of restricted stock units (RSUs).
• The acquisition was at a price of $0 per share, as is typical for RSU conversions.
• Following this acquisition, his direct beneficial ownership increased to 48,202 shares.
• On July 1, 2025, Mr. Hull disposed of 3,483 shares of common stock at a price of $58.34 per share.
• This disposition was for the purpose of satisfying tax withholding obligations related to the RSU vesting.
• After the tax-related disposition, Mr. Hull's direct beneficial ownership stands at 44,719 shares.
• The vested RSUs include portions from grants made in FY23 (June 29, 2022), FY24 (June 28, 2023), and FY25 (June 28, 2024).
• The FY23 grant was 100% service-based, vesting in three equal annual installments.
• The FY24 grant was 30% service-based and 70% performance-based.
• The FY25 grant was 40% service-based and 60% performance-based.

Sentiment

Score: 5

Explanation: The document reports routine insider transactions related to executive compensation (RSU vesting and tax-related sale). It is neutral in sentiment as it reflects standard compensation practices rather than a discretionary buy or sell decision indicating confidence or lack thereof.

Positives

• The vesting of restricted stock units indicates the achievement of service-based and potentially performance-based milestones by the CEO.
• The continued ownership of a significant number of shares (44,719) by the CEO aligns his interests with those of shareholders.

Negatives

• A portion of the vested shares (3,483 shares) was sold to cover tax liabilities, which is a common practice but reduces the CEO's direct shareholding.

Future Outlook

The vesting schedules for the FY24 and FY25 restricted stock units indicate that future share acquisitions are contingent on continued employment and the achievement of specific performance goals over three-year periods.

Industry Context

This filing represents a routine insider transaction related to executive compensation, specifically the vesting of restricted stock units and subsequent tax-related share disposition. Such transactions are common across all industries for publicly traded companies that utilize equity-based compensation plans for their executives.

Stakeholder Impact

• Shareholders: The CEO's continued significant shareholding aligns his interests with shareholders. The tax-related sale is a common practice and not indicative of a lack of confidence.
• Employees: The RSU vesting demonstrates the company's commitment to its executive compensation plan.

Next Steps

• Future vesting of remaining service-based restricted stock units from the FY24 and FY25 grants, subject to continued employment.
• Potential future vesting of performance-based restricted stock units from the FY24 and FY25 grants, contingent on the achievement of performance goals over their respective three-year periods.

Key Dates

Keywords

KEWAUNEE SCIENTIFIC CORP, KEQU, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Executive Compensation, Share Disposition, Thomas David Hull III, CEO, Director